Autosomal dominant hereditary sensory and autonomic neuropathy is a rare genetic condition that affects sensation and automatic body functions. People with this condition often have reduced pain and temperature feeling, numbness in the feet and hands, and problems with sweating or blood pressure. Symptoms usually begin in childhood or early adulthood and tend to be long‑lasting and sometimes progressive. Many living with autosomal dominant hereditary sensory and autonomic neuropathy have a normal life span, but risks include injuries, infections, and foot ulcers because pain signals are blunted. Treatment focuses on prevention, pain management, skin and foot care, and therapies to support balance and blood pressure, and regular checkups help reduce complications.
Overview
Autosomal dominant hereditary sensory and autonomic neuropathySymptoms
Autosomal dominant hereditary sensory and autonomic neuropathy often starts with numbness or burning pain in the feet and hands. People may have injuries or ulcers they don’t feel, plus temperature insensitivity, dizziness on standing, sweating, and digestive or bladder problems.
Outlook and prognosis
Many living with autosomal dominant hereditary sensory and autonomic neuropathy notice slowly worsening numbness, pain‑insensitivity, and temperature regulation issues over years. Falls, unnoticed injuries, and skin or joint problems can accumulate. Regular foot checks, injury prevention, and tailored pain and autonomic care help maintain independence.
Causes and risk factors
Autosomal dominant hereditary sensory and autonomic neuropathy typically stems from a single gene change inherited from an affected parent; it can also arise as a new mutation. Family history drives risk. Injuries, infections, and temperature extremes may worsen complications.
Genetic influences
Genetics are central to Autosomal dominant hereditary sensory and autonomic neuropathy; inherited variants usually drive the condition. A single altered gene copy can be enough to cause symptoms. Family history strongly influences risk, though severity can vary within families.
Diagnosis
Doctors suspect autosomal dominant hereditary sensory and autonomic neuropathy from clinical features like pain sensation loss and autonomic symptoms, then confirm it with genetic tests. Nerve studies or biopsy may support diagnosis of autosomal dominant hereditary sensory and autonomic neuropathy.
Treatment and drugs
Treatment for autosomal dominant hereditary sensory and autonomic neuropathy focuses on symptom control, safety, and preserving function. Care often includes pain management, skin and foot protection, wound care, mobility support, and guidance for sweating or blood pressure changes. A team approach—neurology, pain specialists, dermatology, physical therapy, and podiatry—helps tailor care over time.
Symptoms
In everyday life, parts of the feet or hands may stop sensing pain or temperature clearly, making cuts, burns, or blisters easier to miss. You might notice small changes at first, like socks feeling bunched up when nothing is there, or not feeling a hot bath right away. People sometimes ask about early features of autosomal dominant hereditary sensory and autonomic neuropathy; for many, the first signs involve reduced pain or heat sensing in the feet. What shows up, and how strongly, can differ widely between people and may shift over time.
Pain in the feet and toes can fade, so cuts, blisters, or pressure spots may go unnoticed. This raises the risk of sores or infections if not checked regularly. In autosomal dominant hereditary sensory and autonomic neuropathy, this lost warning signal is common.
Heat or cold may be hard to gauge, so hot water, heating pads, or icy surfaces can injure the skin. Some people notice they burn or chill more easily without much warning.
Burning, stabbing, or electric-shock pains can occur even when areas feel numb. These pains may flare at night or with long periods of standing. Many living with autosomal dominant hereditary sensory and autonomic neuropathy describe mixed numbness and pain.
Wounds on the soles or toes can develop from friction or pressure and may heal slowly. Without pain to prompt rest, they can deepen or get infected.
How people usually first notice Autosomal dominant hereditary sensory and autonomic neuropathy?
Many first notice hereditary sensory and autonomic neuropathy (HSAN) when seemingly minor injuries go unnoticed because they don’t hurt, or when cuts, burns, or blisters heal poorly and lead to infections; in babies and young children, caregivers may spot painless injuries, fingertip wounds from chewing, or unexplained scars. Doctors are often alerted by reduced or absent pain and temperature sensation on exam, along with features like unusually dry or flushed skin, altered sweating, blood pressure swings, or fainting spells—clues to the “autonomic” part of the condition. Because HSAN can be autosomal dominant, the first signs of autosomal dominant hereditary sensory and autonomic neuropathy are sometimes recognized when multiple relatives report similar painless injuries, ulcers on the feet, or nerve testing shows loss of sensation.
Types of Autosomal dominant hereditary sensory and autonomic neuropathy
Autosomal dominant hereditary sensory and autonomic neuropathy is a genetic condition with several recognized clinical variants. Each variant reflects changes in specific genes that affect sensory and autonomic nerve fibers differently, leading to differences in what people feel and how early symptoms of the condition appear. Not everyone will experience every type. Clinicians often describe them in these categories:
HSAN type I
Usually begins in adolescence or adulthood with reduced pain and temperature sensation, often starting in the feet. People may notice painless injuries, slow-healing foot ulcers, or burning nerve pain. Sweating and other autonomic features are usually mild.
HSAN IA (SPTLC1)
Caused by changes in the SPTLC1 gene and often leads to painful nerve symptoms plus loss of protective sensation. Foot ulcers and infections can develop due to unnoticed injuries. Some may have reduced sweating or mild blood pressure regulation issues.
HSAN IB (SPTLC2)
Similar to HSAN IA but due to SPTLC2 gene changes, sometimes with more prominent pain crises. Sensory loss in the legs and feet is common over time. Autonomic symptoms are typically limited but can include reduced sweating.
HSAN IC (ATL1)
Linked to ATL1 gene changes and may include sensory loss with variable pain. Weakness or stiffness in the legs can occur in some families. Autonomic problems are usually mild.
HSAN ID (DNMT1)
Often includes sensory loss along with balance problems, hearing loss, or sleep issues in some. Numbness and burning pain in the feet are common. Autonomic features vary and may be subtle early on.
HSAN IE (DNM2)
Sensory loss with variable nerve pain can develop, sometimes alongside muscle weakness. People may notice tripping, foot drop, or difficulty with fine tasks. Autonomic symptoms are usually limited.
HSAN IF (ATL3)
Sensory loss that tends to start in the feet and progress slowly. Painless injuries and ulcers can occur due to reduced pain perception. Autonomic involvement is generally mild.
HSAN with cough (NGF/TrkA-related)
Some families report a chronic cough triggered by talking or cold air along with sensory loss. Pain perception can be reduced, increasing risk of unnoticed injuries. Autonomic symptoms vary from minimal to mild.
Key differences
Types of autosomal dominant hereditary sensory and autonomic neuropathy differ by gene, age at onset, and balance of pain versus numbness. Some variants bring more neuropathic pain, while others mainly cause numbness and painless injuries. Autonomic features like reduced sweating are usually mild but can vary.
What genetics can tell you about symptoms
Certain gene changes, like in SPTLC1 or SPTLC2, raise toxic fat-like molecules that damage sensory nerves first, causing burning pain, numbness, and injuries you may not feel. Mutations in NTRK1 or IKBKAP often add poor sweating, temperature control problems, and painless fractures.
Causes and risk factors
Autosomal dominant hereditary sensory and autonomic neuropathy is usually caused by a single gene change passed down in a family. It follows an autosomal dominant pattern, so a parent with the change has a 50% chance to pass it on. Some people with autosomal dominant hereditary sensory and autonomic neuropathy are the first in their family because the change happened for the first time. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Diabetes, heavy alcohol use, some chemotherapy drugs, and repeated pressure on the feet or hands can worsen nerve damage and raise the risk of ulcers or infections.
Environmental and biological risk factors
If you’re looking at what may raise the chance that a baby is born with autosomal dominant hereditary sensory and autonomic neuropathy, most influences sit around conception rather than pregnancy care. Some biological risks are written in our genes, others arise through environment. Below are environmental and biological risk factors for autosomal dominant hereditary sensory and autonomic neuropathy, focusing on non-inherited influences that may make a first-time case more likely.
As men age, sperm cells divide many times, raising the chance of a new DNA change when sperm are made. This can slightly increase the chance of autosomal dominant hereditary sensory and autonomic neuropathy starting in a child with no family history. The effect is generally stronger for paternal than maternal age in single-gene conditions.
Random errors can occur when an egg or sperm forms, even without any known exposure. These new, first-time changes can lead to autosomal dominant hereditary sensory and autonomic neuropathy appearing for the first time in a family. They reflect natural background biology rather than anything parents did or didn’t do.
Certain treatments, including some chemotherapy medicines and pelvic or testicular radiation, can damage DNA in reproductive cells for a period after therapy. If conception happens soon after such treatment, the chance of a new DNA change may be higher. Actual risk depends on the medicines used, dose, body area treated, and time since therapy.
Very high doses of ionizing radiation to either parent before conception can increase DNA damage in sperm or egg cells. This may modestly raise the chance of a new change that could trigger a dominant neuropathy. Typical background exposure and standard imaging tests are far below these levels.
Genetic risk factors
Autosomal dominant hereditary sensory and autonomic neuropathy often runs in families, where a genetic change passed from a parent leads to nerve problems that affect feeling and automatic body functions. In most families, one altered copy of a gene is enough to cause the condition, so each child has a 50% chance to inherit it. Risk is not destiny—it varies widely between individuals. The genetic causes of autosomal dominant hereditary sensory and autonomic neuropathy include changes in SPTLC1, SPTLC2, DNMT1, and ATL3, and different genes can influence typical age of onset and additional features.
Dominant inheritance: One changed copy of the gene is enough to cause disease. If a parent has it, each child has a 1 in 2 (50%) chance to inherit the change. Males and females are affected equally.
SPTLC1 variants: Changes in SPTLC1 are the most common genetic cause. They often lead to symptoms starting in the teen years or adulthood. Severity can vary widely, even within the same family.
SPTLC2 variants: Less common changes in SPTLC2 can cause a similar pattern of nerve damage. Age when problems begin can range from adolescence to mid-adulthood. Some families notice milder sensory loss at first.
DNMT1 variants: Changes in DNMT1 can cause neuropathy along with hearing loss or memory and thinking changes in some families. Symptoms typically begin in adulthood. The mix of features can differ between relatives.
ATL3 variants: Changes in ATL3 are a recognized cause of autosomal dominant HSAN. They more often affect feeling in the hands and feet, with variable autonomic involvement. Onset and severity vary.
De novo changes: Sometimes the genetic change happens for the first time in the egg or sperm, so there is no prior family history. In that case, brothers and sisters usually have a low chance of being affected. If the individual has children, each child has a 50% chance to inherit the change.
Variable penetrance: Not everyone who carries a gene change will develop clear signs at the same age or to the same degree. Some carriers may have very mild findings that go unnoticed for years. This can make family patterns hard to recognize.
Genetic heterogeneity: Several different genes can cause the same condition. A negative result in one gene does not rule out others. Multigene testing can clarify which gene is involved in a family.
Lifestyle risk factors
Lifestyle habits do not cause Autosomal dominant hereditary sensory and autonomic neuropathy, but they can influence symptom control, injury risk, and complications. Understanding how lifestyle affects Autosomal dominant hereditary sensory and autonomic neuropathy can help you protect insensate skin, stabilize autonomic symptoms, and support healing. Choices around activity, footwear, hydration, and substances directly change day-to-day safety and long-term outcomes.
Daily visual checks can catch blisters, cuts, and pressure spots you might not feel. Moisturizing and promptly dressing minor wounds help prevent ulcers and infections.
Protective, well-cushioned shoes with proper fit reduce pressure sores and unnoticed fractures. Avoiding barefoot walking and using custom inserts can prevent skin breakdown.
Running, jumping, and contact sports increase joint and bone injury that may go unnoticed. Choosing lower-impact options like cycling or swimming protects insensate feet and ankles.
Low-impact, balance-focused training preserves strength while limiting falls from dizziness. Slow position changes and longer warm-ups can ease orthostatic symptoms.
Risk prevention
Autosomal dominant hereditary sensory and autonomic neuropathy (HSAN) can’t be prevented entirely because it’s a genetic condition, but many risks and complications can be lowered. Prevention works best when combined with regular check-ups. Recognizing early symptoms of autosomal dominant hereditary sensory and autonomic neuropathy can guide safety steps, like protecting numb areas and managing blood pressure changes. The goal is to prevent injuries, infections, and crises related to temperature, blood pressure, and digestion.
Schedule routine visits with neurology, podiatry, and primary care. Monitoring blood pressure, heart rhythm, and skin can catch issues early.
Look over feet, hands, and pressure points every day. Catching blisters, cracks, or burns early helps prevent ulcers and infections in HSAN.
Wear well‑fitting, cushioned shoes and moisture‑wicking socks. Consider custom orthotics to reduce pressure points in areas with reduced feeling.
Use bath thermometers, lower water heater settings, and add non‑slip mats. Install smoke and carbon‑monoxide alarms to reduce burn and safety risks when sensation is reduced.
Transmission
Autosomal dominant hereditary sensory and autonomic neuropathy is a genetic condition, not an infection, so it cannot be caught or spread through casual contact. In an autosomal dominant pattern, a change in one copy of the gene is enough to cause the condition; if a parent is affected, each child has a 1 in 2 (50%) chance of inheriting it, regardless of sex. Sometimes the first person in a family is affected because of a new (de novo) gene change, and that person can then pass it on in the same way. The genetic transmission of Autosomal dominant hereditary sensory and autonomic neuropathy can show differences in age of onset and severity, even among relatives. If you’re planning a pregnancy, a genetics professional can explain how Autosomal dominant hereditary sensory and autonomic neuropathy is inherited and discuss options such as prenatal testing or IVF with embryo testing.
When to test your genes
Genetic testing makes sense if you have numbness, pain loss, or sweating problems starting young, plus a parent or close relative with similar nerve issues. Test sooner if symptoms worsen over time, injuries heal poorly, or ulcers keep returning. Results can guide surveillance, foot care, pain strategies, and family planning.
Diagnosis
People often seek answers after repeated painless injuries to the feet or slow-healing ulcers, sometimes with dizzy spells on standing or changes in sweating. Getting a diagnosis is often a turning point toward answers and support. For autosomal dominant hereditary sensory and autonomic neuropathy, doctors look for a pattern of sensory loss and autonomic changes and then confirm with genetic tests. In many cases, the genetic diagnosis of Autosomal dominant hereditary sensory and autonomic neuropathy clarifies the subtype and guides family counseling.
Doctors check sensation to temperature, pinprick, and vibration, and look for painless sores or joint changes. They also assess for autonomic features such as dry eyes, faintness on standing, or altered sweating.
A detailed family and health history can help identify an autosomal dominant pattern across generations. This can point toward Autosomal dominant hereditary sensory and autonomic neuropathy and guide which tests to order.
A neuropathy gene panel or sequencing looks for changes in genes linked to this condition. Finding a causative variant confirms Autosomal dominant hereditary sensory and autonomic neuropathy and can inform testing for relatives.
Nerve conduction tests often show reduced sensory signals with relatively preserved muscle nerve function. These patterns support a sensory-predominant neuropathy consistent with this diagnosis.
Stages of Autosomal dominant hereditary sensory and autonomic neuropathy
Autosomal dominant hereditary sensory and autonomic neuropathy does not have defined progression stages. The course can vary widely—even within the same family—and the condition is grouped by genetic cause rather than moving through set steps. Doctors usually piece together the diagnosis by combining your story and exam with nerve studies and, in some cases, a skin biopsy; early symptoms of autosomal dominant hereditary sensory and autonomic neuropathy may include reduced pain or temperature sensation, slow-healing sores, or dizziness when standing. Genetic testing may be offered to clarify certain risks.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after hearing a diagnosis of autosomal dominant hereditary sensory and autonomic neuropathy. The outlook is not the same for everyone, but most people notice changes in sensation first—numbness, reduced pain or temperature awareness—and then, over years, issues like ulcers, infections, joint injuries, or lightheadedness from blood‑pressure drops. Early symptoms of autosomal dominant hereditary sensory and autonomic neuropathy may start in adolescence or adulthood and tend to progress slowly. Doctors call this the prognosis—a medical word for likely outcomes. Serious complications usually come from injuries that go unnoticed, slow‑healing wounds, or repeated infections in the feet and hands rather than from the nerves themselves suddenly failing.
Looking at the long-term picture can be helpful. With attentive foot and skin care, prompt treatment of wounds, and protection from burns and pressure, many people maintain mobility and independence for decades. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Some families have milder forms with mainly sensory loss, while others also have more pronounced autonomic symptoms such as abnormal sweating or blood‑pressure swings. Life expectancy is often near typical when complications are prevented early, but severe, untreated infections (including bone infections) or injuries can raise the risk of amputation and, rarely, can affect survival.
Early care can make a real difference. Regular visits with neurology, podiatry, and rehabilitation, along with safe‑shoe wear, daily skin checks, and fall‑prevention strategies, help limit complications and keep day‑to‑day life steadier. Genetic testing can sometimes provide more insight into prognosis, but not everyone with the same gene change will have the same outlook. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Living with autosomal dominant hereditary sensory and autonomic neuropathy often means gradual changes that touch sensation, movement, and automatic body functions over many years. Long-term effects vary widely, and two people in the same family can have very different experiences. Many features evolve slowly, which can make them easy to miss in the early stages. Doctors may track these changes over years to see how they shift over time.
Reduced ability to feel pain and temperature can lead to unnoticed cuts or burns. Injuries may be more severe because warning signals are blunted. This loss often progresses slowly.
Some develop shooting, burning, or electric-like pains even with numbness elsewhere. These pains can flare in bouts and then settle. Over time, patterns may shift in intensity.
Recurrent ulcers on the feet or hands may heal slowly. Repeated pressure or friction can break the skin without much warning. Scarring and thickened skin can build up.
Skin breaks can let infections take hold, sometimes reaching bone. Severe, repeated infections can raise the risk of partial amputations. Early detection often changes the course.
How is it to live with Autosomal dominant hereditary sensory and autonomic neuropathy?
Living with autosomal dominant hereditary sensory and autonomic neuropathy often means juggling numbness or reduced pain sensation with changes in sweating, temperature control, and sometimes blood pressure drops when standing. Daily life can require extra safety routines—checking skin and feet for unnoticed injuries, choosing protective footwear, managing hydration and heat, and planning around fatigue or dizziness—to prevent problems before they escalate. People close to you may become partners in safety and support, helping watch for wounds, learning how to respond to faintness or falls, and adjusting shared activities to stay comfortable and active. Many find that with consistent self-checks, smart environmental choices, and regular follow-up with clinicians, they can protect their independence and enjoy a full life while minimizing complications.
Treatment and drugs
Treatment for autosomal dominant hereditary sensory and autonomic neuropathy focuses on easing symptoms, protecting injured areas you may not feel well, and preventing complications like chronic wounds or infections. Supportive care can make a real difference in how you feel day to day, including regular skin and foot checks, prompt care of cuts or burns, cushioned footwear, and physical or occupational therapy to maintain balance and hand function. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as pain‑modulating medicines for nerve pain, topical treatments for localized pain, and measures for autonomic symptoms like hydration, salt adjustments, compression stockings, or medications for blood‑pressure swings, sweating problems, or gut and bladder issues. If first-line treatments don’t help, specialists may try second-line options, and surgery may be considered for severe joint damage or nonhealing ulcers. Genetic counseling can help families understand inheritance and plan ahead, and regular follow-up with neurology, podiatry, dermatology, and rehabilitation medicine helps tailor care as needs change.
Non-drug treatment
Living with autosomal dominant hereditary sensory and autonomic neuropathy can affect feeling, temperature control, blood pressure, and how your skin heals in everyday life. Non-drug treatments often lay the foundation for preventing injuries, easing symptoms, and staying active. Plans are tailored to your symptoms and routines, and usually involve a coordinated team across rehab, skin care, and autonomic support.
Check feet and hands daily for blisters, cuts, or pressure spots. Moisturize dry skin, keep nails trimmed straight, and schedule regular podiatry visits.
Wear cushioned, well‑fitting shoes with seamless socks to prevent rubbing. Consider orthotic inserts and avoid walking barefoot, even at home.
Build strength, balance, and joint flexibility to steady your gait. Targeted training can lower fall risk and protect numb areas during activity.
Adapt home and work tasks to reduce skin friction and pressure. Simple tools like padded grips and jar openers can protect hands and save energy.
Your genes may have an impact on how drugs work for you
Medications used in autosomal dominant hereditary sensory and autonomic neuropathy can work differently depending on gene changes that alter nerve signaling, pain pathways, or drug‑processing enzymes. Genetic testing may guide choices and dosing, helping balance pain relief with side‑effect risks.
Pharmacological treatments
Medicines for autosomal dominant hereditary sensory and autonomic neuropathy focus on easing nerve pain and stabilizing body functions like blood pressure, stomach movement, bladder control, and sweating. Drugs that target symptoms directly are called symptomatic treatments. While medicines can’t reverse nerve damage, they can reduce day‑to‑day discomfort and complications. Choices are tailored to your symptoms, which may evolve from early symptoms of autosomal dominant hereditary sensory and autonomic neuropathy to more settled patterns over time.
Helps calm burning or shooting nerve pain. Doses are usually increased gradually to find a helpful level with tolerable side effects.
Eases nerve pain and can improve sleep disrupted by discomfort. Some may notice dizziness or swelling in the legs.
Treats neuropathic pain and may lift mood if chronic pain has worn you down. It can cause nausea at first, which often settles.
Low bedtime doses can reduce nerve pain and improve sleep. Dry mouth and morning grogginess are possible, so dosing may be adjusted slowly.
Genetic influences
In most families, this condition is inherited in an autosomal dominant way—one changed copy of a gene is enough, and each child of an affected parent has a 50% chance to inherit it. The genes involved help peripheral nerves sense pain and temperature and support automatic functions like sweating and steady blood pressure; when a change disrupts that work, symptoms may develop gradually. Having a gene change doesn’t always mean you will develop the condition. Even within one family, age of onset and severity can differ, so early symptoms of Autosomal dominant hereditary sensory and autonomic neuropathy may appear in one relative during the teen years while another has only mild numbness much later in adulthood. Several different genes can cause Autosomal dominant hereditary sensory and autonomic neuropathy, and in some families the change happens for the first time in the child, with no prior history. Genetic counseling and appropriate testing can identify the specific gene change, confirm the diagnosis, and clarify risks for relatives who may be planning for pregnancy or noticing new symptoms.
Is Autosomal dominant hereditary sensory and autonomic neuropathy genetic?
Genetics are central to Autosomal dominant hereditary sensory and autonomic neuropathy; inherited variants usually drive the condition. A single altered gene copy can be enough to cause symptoms. Family history strongly influences risk, though severity can vary within families.
Pharmacogenetics—how genetics influence drug effects
For people living with Autosomal dominant hereditary sensory and autonomic neuropathy, treatment often centers on nerve pain control, preventing injuries, and managing symptoms like blood pressure drops or sweating changes—and your genes can influence how your body handles some of the medicines used. Genetic testing can sometimes identify how your body processes certain pain medicines, which can help your clinician choose safer doses or different options. For example, differences in a liver enzyme called CYP2D6 can make codeine or tramadol either too weak to help or, in some cases, too strong, so your care team may avoid these drugs or adjust the plan accordingly. Tricyclic antidepressants used for nerve pain (such as amitriptyline or nortriptyline) are also influenced by genes like CYP2D6 and CYP2C19, and dose guidance based on genetics may reduce side effects like sleepiness or dry mouth. If a sodium‑channel medicine like carbamazepine is considered, checking for HLA-B*15:02 (and sometimes HLA-A*31:01) before starting can lower the risk of rare but serious skin reactions, especially in people with East or Southeast Asian ancestry. Some anti‑inflammatory pain relievers, including ibuprofen or celecoxib, are affected by CYP2C9 variants, where lower doses may be advised for certain people; your overall health, kidney function, and stomach risk still play a major role in the treatment of Autosomal dominant hereditary sensory and autonomic neuropathy.
Interactions with other conditions
Living with Autosomal dominant hereditary sensory and autonomic neuropathy alongside another condition can change how symptoms show up and how you manage daily life. Doctors call it a “comorbidity” when two conditions occur together, and diabetes is a common example where nerve damage, foot ulcers, and slow wound healing can add up and raise infection risk. Early symptoms of Autosomal dominant hereditary sensory and autonomic neuropathy can be mistaken for diabetic neuropathy or vitamin B12 deficiency, which may delay the right diagnosis and care. Medicines that lower blood pressure or reduce sweating (including some antidepressants and bladder or allergy medicines) can worsen lightheadedness, overheating, or heart-rate swings; anesthesia and surgery also need extra planning because of temperature and blood pressure instability. If bladder nerves are affected, urinary retention can lead to recurrent urinary tract infections, and unnoticed skin injuries can progress to deep infections in the feet or bones, especially if another illness affects immunity. It’s worth asking your care team how other health issues—or treatments like chemotherapy, heavy alcohol use, or low B12—might intensify nerve symptoms so your plan can be adjusted early.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described burning or absent pain sensation, unexpected injuries that didn’t hurt, and skin that healed poorly after repeated wounds—clues we now recognize in autosomal dominant hereditary sensory and autonomic neuropathy. Families sometimes recalled a parent and grandparent who “never felt cuts,” or a relative who often sprained ankles because numb feet hid early warning pain. These everyday stories hinted that the condition could run in families and affect more than just feeling—sweating, temperature control, and blood pressure changes were part of the picture for some.
First described in the medical literature as a group of inherited “sensory neuropathies,” early reports focused on striking injuries and painless ulcers. Doctors noted that people with this condition could develop foot sores from walking or burns from cooking because pain signals were dulled. Over time, descriptions became more precise, separating autosomal dominant hereditary sensory and autonomic neuropathy from other neuropathies that start in childhood, involve different nerves, or follow different inheritance patterns. Not every early description was complete, yet together they built the foundation of today’s knowledge.
In recent decades, knowledge has built on a long tradition of observation. Careful family studies showed that when one parent is affected, children have a 50% chance of inheriting the condition, consistent with autosomal dominant inheritance. Clinicians also saw differences between families: some had mainly numbness and pain loss in the feet and hands, while others had more issues with sweating or blood pressure. These patterns helped define subtypes and clarified that severity can vary even within the same family.
Advances in genetics confirmed what families had long noticed. Researchers linked specific gene changes to nerve fiber damage that starts at the longest nerves, explaining why symptoms often begin in the toes and fingertips. This work also clarified that sensory loss can come first, with autonomic features—such as heat intolerance or changes in sweating—emerging later or remaining mild in some people. As medical science evolved, diagnostic tools like nerve conduction studies and skin biopsies allowed doctors to measure small nerve fiber loss, supporting what patients had been reporting for generations.
Today, the history of autosomal dominant hereditary sensory and autonomic neuropathy continues to shape care. Knowing the condition’s history helps explain why early symptoms of hereditary sensory neuropathy may be subtle—like unnoticed blisters after a long walk—and why regular foot checks, skin care, and injury prevention became standard advice. It also reminds us that while names and classifications have shifted, the heart of the story has always been the same: listening to families, tracking patterns across generations, and pairing those observations with modern genetics to guide safer, earlier care.